Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stress-induced ligands are a group of cell surface proteins, including MICA, MICB, and ULBP1-6, that are upregulated in response to cellular stress, such as DNA damage, oncogenic transformation, infection, or oxidative stress. These ligands are recognized by the NKG2D receptor on natural killer (NK) cells and certain T cell subsets, triggering immune responses leading to the elimination of abnormal cells. Tumor cells can evade immune detection by shedding these ligands from their surface.
Engagement of NKG2D on NK cells and T cells, leading to downstream signaling through ITAM motifs and kinases like Syk/Zap70. This activates cytotoxicity and cytokine production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stress-induced ligand recognized by NK receptor.